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As the prevalence of the neurodegenerative diseases is steady increasing and most of the 
patients are elderly people, discovering and formulating effective, easy-to- use and non-
invasive therapies are two of the main goals of pharmaceutical technology and regulatory 
affairs. In the presence of the blood brain barrier just few medications show good penetrating 
and effectiveness, especially that this barrier has specific properties suit only the lipophilic and 
very tiny particles. Nowadays, targeted Nano therapies greatly draw attention as new possible 
ways to deliver medicines showing promising approach to improve their therapeutic index 
while reducing their side effects. Nose-to-brain as a way of delivering medicines considers one 
of the most recent routes shows fast and effective action and by applying lipid-based Nano-
systems, the chance of obtaining the required penetration and optimum properties can be 
raised up, so here we discuss the types of lipid based Nano-systems, their properties, 
advantages and disadvantages that made them preferable as careers for nose-to-brain 
delivery application of some therapies targeted neurodegenerative disease. 
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